Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

Blood. 2022 Jan 6;139(1):134-137. doi: 10.1182/blood.2021014232.

¹ Department of Clinical Hematology, Hôpitaux Universitaires Pitié Salpêtrière, Paris, France.
² Department of Clinical Hematology, Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Henri Mondor, Créteil, France.
³ Department of Clinical Hematology, Angers University Hospital, Angers, France.
⁴ Department of Clinical Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
⁵ Department of Clinical Hematology, Nantes University Hospital, Nantes, France.
⁶ Department of Hematology, Nancy Hospital, Nancy, France.
⁷ Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, Service de greffe de cellules souches hematopoïétiques, Toulouse, France.
⁸ Department of Clinical Hematology, Besançon University Hospital, Besançon, France.
⁹ Department of Clinical Hematology, Centre Hospitalier Universitaire (CHU) de Rennes, Rennes, France.
¹⁰ Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire de Caen, Caen.
¹¹ Department of Hematology and Cell Therapy, CHU de Bordeaux, Bordeaux, France.
¹² Department of Hematology, CHU de Nice, Université Cote d'Azur, Nice, France.
¹³ Department of Hematology, CHU Amiens, Amiens, France.
¹⁴ Institut de Cancérologie Gustave Roussy, Villejuif, France.
¹⁵ Department of Clinical Hematology, CHU de Grenoble, Grenoble, France; and.

No abstract available

Publication types